flow jo software (Ashland Inc)
86
Structured Review
Ashland Inc
flow jo software
Flow Jo Software, supplied by Ashland Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flow+jo+software/flow+jo+software/pm42092124-58-4-7
Average 86 stars, based on 1 article reviews
Flow Jo Software, supplied by Ashland Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flow+jo+software/flow+jo+software/pm42092124-58-4-7
Average 86 stars, based on 1 article reviews
flow jo software - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Software:Article Title: Molecular mechanisms of apoptosis induction in KG1a leukemia cells by the Ginkgo biloba extract (EGb) Article Snippet: The condition known as acute myeloid leukemia (AML) is heterogeneous and complex, with fast cell growth, an aggressive clinical course, and a relatively high fatality rate (Siegel et al. 2018; Zonouz et al. 2024).. The bulk of patients are older adults, who have a harder time recovering from the condition; as a result, the 5-year overall survival rate is just about 27% (Shallis et al. 2019).. At the moment, the primary treatment for leukemia patients is chemotherapy and bone marrow transplantation. Article Title: Engineering selective PI3Kγ inhibitors with antitumor and immunomodulatory potentials Article Snippet: .. The TAMs were examined with a flow cytometer (BD Biosciences) and analyzed using the Article Title: Lactate reprograms PGE2 metabolism via GPR81 inhibits COX2 to relieved psoriasis. Article Snippet: 2.4 Flow cytometry The spleens of mice in each group were collected, prepared as single cell suspensions, washed twice with PBS, added including anti-CD4, CD8, F4/80, CD69, CD206, and MHCII ( BioLegend Cat. No. 107605,RRID:AB_313320,1:100, incubated for 30 min at 4°C with protection from light, and resuspended with PBS, and then on coyoflex LX (BACKMAN, USA) Analyses were performed. .. Data were analysed using Article Title: Atypical memory B cells increase in the peripheral blood of patients with breast cancer regardless of lymph node involvement. Article Snippet: .. The data were analyzed using Article Title: Autophagy and mitophagy-related extracellular mitochondrial dysfunction of cerebrospinal fluid cells in patients with hemorrhagic moyamoya disease. Article Snippet: .. The data were analyzed using Article Title: Engineered liver-derived decellularized extracellular matrix-based three-dimensional tumor constructs for enhanced drug screening efficiency Article Snippet: .. Lastly, the G1, G2 and S-phase proportions were analysed by FCM and cell cycle phase mode in Article Title: Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties Article Snippet: The cell cycle was measured using a MACSOuant Analyzer (Miltenyi Biotec, Gaithersburg, MD, United States). .. Cell cycle analysis was performed based on the distribution of DNA content using Article Title: CD300ld on neutrophils is required for tumour-driven immune suppression. Article Snippet: The immune-suppressive tumour microenvironment represents a major obstacle to effective immunotherapy.. Pathologically activated neutrophils, also known as polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs), are a critical component of the tumour microenvironment and have crucial roles in tumour progression and therapy resistance.. Identification of the key molecules on PMNMDSCs is required to selectively target these cells for tumour treatment. Flow Cytometry:Article Title: Molecular mechanisms of apoptosis induction in KG1a leukemia cells by the Ginkgo biloba extract (EGb) Article Snippet: The condition known as acute myeloid leukemia (AML) is heterogeneous and complex, with fast cell growth, an aggressive clinical course, and a relatively high fatality rate (Siegel et al. 2018; Zonouz et al. 2024).. The bulk of patients are older adults, who have a harder time recovering from the condition; as a result, the 5-year overall survival rate is just about 27% (Shallis et al. 2019).. At the moment, the primary treatment for leukemia patients is chemotherapy and bone marrow transplantation. Article Title: Engineering selective PI3Kγ inhibitors with antitumor and immunomodulatory potentials Article Snippet: .. The TAMs were examined with a flow cytometer (BD Biosciences) and analyzed using the Cell Cycle Assay:Article Title: Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties Article Snippet: The cell cycle was measured using a MACSOuant Analyzer (Miltenyi Biotec, Gaithersburg, MD, United States). .. Cell cycle analysis was performed based on the distribution of DNA content using |